Brain and plasmatic CLUSTERIN are translational markers of Alzheimer's disease - Tournier, Benjamin B.; Ceyzériat, Kelly; Marteyn, Antoine; Amossé, Quentin; Badina, Aurélien M.; Tsartsalis, Stergios; Herrmann, François R.; Zekry, Dina; Millet, Philippe (Brain pathology (Zurich, Switzerland), 2025)
Keywords: 3xTgAD; Aged; Aged, 80 and over; Alzheimer Disease - blood; Alzheimer Disease - diagnosis; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Alzheimer's disease; Animals; Biomarkers; Biomarkers - blood; Biomarkers - metabolism; Brain; Brain - metabolism; Brain - pathology; Clusterin; Clusterin - blood; Clusterin - metabolism; Cognitive ability; Cognitive Dysfunction - blood; Cognitive Dysfunction - metabolism; Cognitive Dysfunction - pathology; Disease Models, Animal; Female; Hippocampus; Humans; Longitudinal Studies; Male; Mice; Mice, Transgenic; Neurodegenerative diseases; Neurofibrillary tangles; Plasma; Rats; Rats, Transgenic; TgF344‐AD; Therapeutic targets; translational; β-Amyloid; 3xTgAD; translational; plasma; Alzheimer's disease; TgF344‐AD; Clusterin